Log in
LON:APH

Alliance Pharma plc (APH.L) Share Forecast, Price & News

GBX 73.40
+0.40 (+0.55 %)
(As of 11/27/2020 04:35 PM ET)
Add
Compare
Today's Range
72.90
Now: GBX 73.40
74.02
50-Day Range
73.10
MA: GBX 74.43
76
52-Week Range
52.17
Now: GBX 73.40
88.90
Volume168,067 shs
Average Volume859,377 shs
Market Capitalization£390.76 million
P/E Ratio34.95
Dividend Yield1.45%
BetaN/A
Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes pharmaceutical and other medical products. It owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also offers medical devices, food supplements, and cosmetics. In addition, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Xonvea, Flamma Franchise, Aloclair, Hydromol, Forceval, Haemopressin, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Read More
Alliance Pharma plc (APH.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.61 out of 5 stars


Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1249-466966
Employees200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£131.34 million
Cash FlowGBX 3.92 per share
Book ValueGBX 51.50 per share

Profitability

Miscellaneous

Market Cap£390.76 million
Next Earnings DateN/A
OptionableOptionable
GBX 73.40
+0.40 (+0.55 %)
(As of 11/27/2020 04:35 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APH News and Ratings via Email

Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alliance Pharma plc (APH.L) (LON:APH) Frequently Asked Questions

How has Alliance Pharma plc (APH.L)'s stock price been impacted by COVID-19?

Alliance Pharma plc (APH.L)'s stock was trading at GBX 73 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APH stock has increased by 0.5% and is now trading at GBX 73.40.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Alliance Pharma plc (APH.L)?

Wall Street analysts have given Alliance Pharma plc (APH.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Alliance Pharma plc (APH.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Alliance Pharma plc (APH.L) pay dividends? What is the dividend yield for Alliance Pharma plc (APH.L)?

Alliance Pharma plc (APH.L) announced a dividend on Tuesday, September 22nd. Shareholders of record on Thursday, December 17th will be paid a dividend of GBX 0.54 per share on Thursday, January 7th. This represents a yield of 0.73%. The ex-dividend date is Thursday, December 17th. The official announcement can be viewed at this link.
View Alliance Pharma plc (APH.L)'s dividend history
.

Who are some of Alliance Pharma plc (APH.L)'s key competitors?

What other stocks do shareholders of Alliance Pharma plc (APH.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma plc (APH.L) investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC.TO) (AC), Ally Financial (ALLY), Aviva plc (AV.L) (AV), BAE Systems plc (BA.L) (BA) and Berry Global Group (BERY).

Who are Alliance Pharma plc (APH.L)'s key executives?

Alliance Pharma plc (APH.L)'s management team includes the following people:
  • Mr. Peter Jonathan Butterfield, CEO & Exec. Director (Age 44, Pay $1.73M)
  • Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 54, Pay $778.53k)
  • Mr. Stephen Kidner, Chief Scientific & Operations Officer
  • Mr. Daniel Thomas, Chief Corp. Devel. Officer
  • Ms. Janice Timberlake, Chief People and Infrastructure Officer
  • Mr. Steve Lobb, Head of Hydromol
  • Mr. David Hope, Head of Secondary Care
  • Mr. Alex Duggan, Chief Commercial Officer
  • Mr. Rajiv Ghidiyal, Head of APAC, EMEA & Americas
  • Mr. Karim Husny, Head of International

What is Alliance Pharma plc (APH.L)'s stock symbol?

Alliance Pharma plc (APH.L) trades on the London Stock Exchange (LON) under the ticker symbol "APH."

How do I buy shares of Alliance Pharma plc (APH.L)?

Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Alliance Pharma plc (APH.L)'s stock price today?

One share of APH stock can currently be purchased for approximately GBX 73.40.

How big of a company is Alliance Pharma plc (APH.L)?

Alliance Pharma plc (APH.L) has a market capitalization of £390.76 million and generates £131.34 million in revenue each year. Alliance Pharma plc (APH.L) employs 200 workers across the globe.

What is Alliance Pharma plc (APH.L)'s official website?

The official website for Alliance Pharma plc (APH.L) is www.alliancepharma.co.uk.

How can I contact Alliance Pharma plc (APH.L)?

Alliance Pharma plc (APH.L)'s mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966.

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.